Further studies should be conducted to identify the subset of activated T cells under FcRn immune regulation and potential disease-contributing molecular pathways to precisely define the specific pathology of each autoimmune disease and the therapeutic universality of the FcRn blockage. The gene discussed is FCGRT; the disease is autoimmune disease.